Qualigen Therapeutics Stock Alpha and Beta Analysis
| QLGN Stock | USD 4.47 0.31 6.49% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Qualigen Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Qualigen Therapeutics over a specified time horizon. Remember, high Qualigen Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Qualigen Therapeutics' market risk premium analysis include:
Beta 0.76 | Alpha (1.07) | Risk 6.8 | Sharpe Ratio (0.13) | Expected Return (0.87) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Qualigen |
Qualigen Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Qualigen Therapeutics market risk premium is the additional return an investor will receive from holding Qualigen Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Qualigen Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Qualigen Therapeutics' performance over market.| α | -1.07 | β | 0.76 |
Qualigen Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Qualigen Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Qualigen Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Qualigen Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Qualigen Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Qualigen Therapeutics shares will generate the highest return on investment. By understating and applying Qualigen Therapeutics stock market price indicators, traders can identify Qualigen Therapeutics position entry and exit signals to maximize returns.
Qualigen Therapeutics Return and Market Media
The median price of Qualigen Therapeutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 8.08 with a coefficient of variation of 27.81. The daily time series for the period is distributed with a sample standard deviation of 1.98, arithmetic mean of 7.12, and mean deviation of 1.81. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Qualigen Therapeutics, Inc. Announces Pricing of 3.46 Million Public Offering | 09/05/2024 |
2 | Univest Securities, LLC Announces Closing of 3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. | 09/06/2024 |
3 | Acquisition by Kruger Kurt H of 40000 shares of Qualigen Therapeutics subject to Rule 16b-3 | 09/18/2024 |
4 | Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel | 09/20/2024 |
5 | Insider Trading | 10/08/2024 |
6 | Acquisition by Shishir Sinha of 100000 shares of Qualigen Therapeutics subject to Rule 16b-3 | 10/18/2024 |
7 | Shares Expected to Begin Trading on Split-Adjusted Basis onNovember 5, 2024 | 11/01/2024 |
8 | Qualigen Therapeutics Announces 4.5 Million Private Placement of Convertible Preferred Shares | 11/19/2024 |
9 | Univest Securities, LLC Announces Successful Closing of 5. ... | 11/25/2024 |
About Qualigen Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Qualigen or other stocks. Alpha measures the amount that position in Qualigen Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 4.89 | 6.94 | 2.34 | 2.23 | Days Of Inventory On Hand | 88.95 | 134.56 | 121.11 | 127.16 |
Qualigen Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Qualigen Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Qualigen Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Qualigen Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Qualigen Therapeutics. Please utilize our Beneish M Score to check the likelihood of Qualigen Therapeutics' management manipulating its earnings.
| 7th of May 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Qualigen Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Qualigen Therapeutics Backtesting, Qualigen Therapeutics Valuation, Qualigen Therapeutics Correlation, Qualigen Therapeutics Hype Analysis, Qualigen Therapeutics Volatility, Qualigen Therapeutics History and analyze Qualigen Therapeutics Performance. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Qualigen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.